The oral gamma secretase inhibitor is approved as a single agent for adults with progressing desmoid tumours requiring ...

Merck KGaA's recently acquired SpringWorks unit has claimed EU approval for Ogsiveo, becoming the first approved therapy for ...

The collaboration will explore RNA-based small molecule drug candidates aimed at neurological conditions where existing ...

Six digital health technologies (DHTs) that can help with the rehabilitation of people with cardiovascular disease have been ...